AMP
Pathologists See Value Balance Shift Toward Comprehensive Sequencing for Hematologic Cancers
Premium
At the AMP annual meeting last week, speakers at multiple workshops said their field is reaching a tipping point as the clinical utility of NGS further solidifies.
At the AMP annual meeting last week, a Johns Hopkins researcher detailed an Oxford Nanopore flu sequencing workflow optimized with novel New England Biolabs reagents.
CMS Final Pricing for Genomic Procedure Codes Leaves Lab, Industry Stakeholders Wanting More
Premium
After going through the gapfill process and releasing final pricing for six codes related to genomic sequencing procedures, the final pricing still has stakeholders worried.
Roche Prepping Fully Automated Comprehensive Genomic Profiling Sequencing Kit for Q1 2025 Launch
Premium
At the AMP annual meeting, Roche previewed the Avenio Tumor Tissue CGP Automated Kit, which runs on the Illumina NovaSeq 6000 and features a new pan-tumor HRD signature score.
Element Biosciences, Qiagen Targeted NGS Helps ID Urine-Based cfDNA Biomarkers in Breast Cancer
Premium
At the AMP annual meeting, a University Hospital Leipzig researcher described using the NGS workflow to find promising urine-based biomarkers in triple-negative breast cancer.